These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 19117040

  • 1. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).
    Manfrin E, Mariotto R, Remo A, Reghellin D, Falsirollo F, Dalfior D, Bricolo P, Piazzola E, Bonetti F.
    Cancer; 2009 Feb 01; 115(3):499-507. PubMed ID: 19117040
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER, Park A, Borgen PI, Morris E, Montgomery LL.
    Ann Surg Oncol; 2007 Mar 01; 14(3):1051-7. PubMed ID: 17206485
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Management of non-palpable breast lesions with vacuum-assisted large core needle biopsies (Mammotome). Experience with 560 procedures at the Val d'Aurelle Center].
    Bibeau F, Chateau MC, Masson B.
    Ann Pathol; 2003 Dec 01; 23(6):582-92. PubMed ID: 15094596
    [Abstract] [Full Text] [Related]

  • 6. Minimal invasive biopsy results of "uncertain malignant potential" in digital mammography screening: high prevalence but also high predictive value for malignancy.
    Weigel S, Decker T, Korsching E, Biesheuvel C, Wöstmann A, Böcker W, Hungermann D, Roterberg K, Tio J, Heindel W.
    Rofo; 2011 Aug 01; 183(8):743-8. PubMed ID: 21506072
    [Abstract] [Full Text] [Related]

  • 7. [Cancer risk in breast lesions: diagnostic and therapeutic strategy].
    Bove F, Bilancio G, De Falco M, Parmeggiani D, Sperlongano P, Barbarisi A, Parmeggiani U.
    Minerva Chir; 2003 Jun 01; 58(3):375-83. PubMed ID: 12955059
    [Abstract] [Full Text] [Related]

  • 8. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S, Thoresen S, Tretli S.
    Cancer; 2004 Oct 01; 101(7):1501-7. PubMed ID: 15378474
    [Abstract] [Full Text] [Related]

  • 9. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM, Maitra A, Wistuba II, Alberts A, Albores-Saavedra J, Gazdar AF.
    J Surg Res; 1999 May 01; 83(1):13-8. PubMed ID: 10210636
    [Abstract] [Full Text] [Related]

  • 11. Risk of needle tract seeding of breast cancer: cytological results derived from core wash material.
    Uematsu T, Kasami M.
    Breast Cancer Res Treat; 2008 Jul 01; 110(1):51-5. PubMed ID: 17674195
    [Abstract] [Full Text] [Related]

  • 12. Benign papilloma on core biopsy requires surgical excision.
    Skandarajah AR, Field L, Yuen Larn Mou A, Buchanan M, Evans J, Hart S, Mann GB.
    Ann Surg Oncol; 2008 Aug 01; 15(8):2272-7. PubMed ID: 18473143
    [Abstract] [Full Text] [Related]

  • 13. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.
    Mridha AR, Iyer VK, Kapila K, Verma K.
    Indian J Pathol Microbiol; 2006 Jul 01; 49(3):334-40. PubMed ID: 17001879
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
    Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, Mac Bride MB, Dilaveri CA, Wahner-Roedler DL, Ghosh K, Visscher DW.
    Mayo Clin Proc; 2014 Apr 01; 89(4):536-47. PubMed ID: 24684875
    [Abstract] [Full Text] [Related]

  • 15. Relation between component parts of fibrocystic disease complex and breast cancer.
    Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH.
    J Natl Cancer Inst; 1978 Oct 01; 61(4):1055-63. PubMed ID: 279711
    [Abstract] [Full Text] [Related]

  • 16. Follow-up recommendations for benign breast biopsies.
    Shin S, Schneider HB, Cole FJ, Laronga C.
    Breast J; 2006 Oct 01; 12(5):413-7. PubMed ID: 16958957
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for benign breast biopsies: a nested case-control study in the Alberta breast screening program.
    Friedenreich CM, Bryant HE, Alexander F, Hugh J, Danyluk J, Page DL.
    Cancer Detect Prev; 2001 Oct 01; 25(3):280-91. PubMed ID: 11425270
    [Abstract] [Full Text] [Related]

  • 18. Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre.
    Kumaroswamy V, Liston J, Shaaban AM.
    J Clin Pathol; 2008 Jun 01; 61(6):766-9. PubMed ID: 18326021
    [Abstract] [Full Text] [Related]

  • 19. [High-risk focal breast lesions in echography and mammography].
    Gozzi G, Delendi M, Bazzocchi M, Zuiani C, Vasciaveo A, Ferrara P.
    Radiol Med; 1989 Dec 01; 78(6):603-6. PubMed ID: 2697029
    [Abstract] [Full Text] [Related]

  • 20. Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies.
    Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD.
    Cancer; 2006 Apr 01; 106(7):1453-61. PubMed ID: 16502407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.